SCHEMBL6740264

SCHEMBL6740264

CCCCCOc1ccc(S(=O)(=O)C(=[N+]=[N-])S(=O)(=O)c2ccc(OCCCCC)cc2C)c(C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDIA6 Q15084 1/20 0.55
THRA P10827 3/20 0.44
THRB P10828 3/20 0.44
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
NR5A1 Q13285 1/20 0.40
TSHR P16473 2/20 0.40
TP53 P04637 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PLA2G4B P0C869 2/20 0.39
LTA4H P09960 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6738526 0.99 PDIA6 (0.53) PDIA6THRATHRBNPC1RAB9A
SCHEMBL6739637 0.99 PDIA6 (0.53) PDIA6THRATHRBNPC1RAB9A
SCHEMBL385151 0.99 PDIA6 (0.53) PDIA6THRATHRBNPC1RAB9A
SCHEMBL30667567 0.99 PDIA6 (0.53) PDIA6THRATHRBNPC1RAB9A
SCHEMBL6741835 0.99 PDIA6 (0.53) PDIA6THRATHRBNPC1RAB9A
SCHEMBL6736812 0.99 PDIA6 (0.53) PDIA6THRATHRBNPC1RAB9A
SCHEMBL6744176 0.99 PDIA6 (0.53) PDIA6THRATHRBNPC1RAB9A
SCHEMBL6743631 0.99 PDIA6 (0.53) PDIA6THRATHRBNPC1RAB9A
SCHEMBL6741158 0.97 PDIA6 (0.54) PDIA6THRATHRBNPC1RAB9A
SCHEMBL5843877 0.87 PDIA6 (0.42) PDIA6THRATHRBNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6689530-B2 ULTRAVIOLET LITHOGRAPHY MICROFABRICATION WITH IMPROVED RESOLUTION AND PATTERN PROFILE AFTER DEVELOPMENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-02-10 US disclosed
US-20030180653-A1 Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030180653-A1 Novel sulfonyldiazomethanes, photoacid generations, resist compositions, and patterning process CACNA1A, KCNA1, POLL PDIA6 2603/4885THRA 4108/4885THRB 4655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.